Mortality Risk in Rheumatoid Lung Patients
Jan 20, 2021
Recent News
Read ArticleA Medicare claims analysis of rheumatoid arthritis (RA) patients showed that RA-associated interstitial lung disease (RA-ILD) was seen in nearly 5% of patients and was found to increase mortality risks, including respiratory and cancer mortality not explained by other factors.
Epidemiologic study of #SLE from CDC & lupus registries estimates there are 204,295 SLE pts in USA (2018).
Links:
Dr. John Cush @RheumNow ( View Tweet)
Jan 21, 2021
My note to the FDA staff: https://t.co/n2Pr2Kzrre
Dr. Janet Woodcock @DrWoodcockFDA ( View Tweet)
Jan 21, 2021
Toci led to poorer outcomes in this study. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial | The BMJ https://t.co/95zaq2CEUU
Dr Philip Robinson @philipcrobinson ( View Tweet)
Jan 21, 2021
UTSW Rheum Grand Rounds - IgG4 Dz - Plasmablasts may be a useful biomarker; but is not generally available in clinical labs (must be done on fresh whole blood) @UTSWIMchief https://t.co/GlEKw0KD3O
Dr. John Cush @RheumNow ( View Tweet)
Jan 21, 2021
UTSW Rheum Grand Rounds - IgG4 Dz common lab findings: hypergammaglobulinemia is common but elevated ESR/CRP are not. Most have elevated IgG4 serum levels @UTSWIMchief https://t.co/wR5FEqZTsX
Dr. John Cush @RheumNow ( View Tweet)
Jan 21, 2021
UTSW Rheum Grand Rounds - IgG4 Dz commonly presents as major salivary and lacrimal gland enlargement, orbital disease, autoimmune pancreatitis, retroperitoneal (mass) fibrosis or tubulointerstitial nephritis. @UTSWIMchief
Dr. John Cush @RheumNow ( View Tweet)
Jan 21, 2021
UTSW Rheum Grand Rounds - IgG4 Dz renal involvement; most common is tubulointerstitial nephritis
@UTSWIMchief https://t.co/q8dZbgmvfK
Dr. John Cush @RheumNow ( View Tweet)
Jan 21, 2021
UTSW Rheum Grand Rounds - Dr. Andres Quiceno on "IgG4 related Disease" Histologic criteria req >40% on IgG4/IgG cells @UTSWIMchief https://t.co/2kOioCdFiM
Dr. John Cush @RheumNow ( View Tweet)
Jan 21, 2021
Being "busy" is about priorties and productivity.
Dr. John Cush @RheumNow ( View Tweet)
Jan 21, 2021
Inequities in Telemedicine During COVID-19
Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began but what if you don't have access to reliable technology?
Links:
Dr. John Cush @RheumNow ( View Tweet)
Jan 21, 2021
Low Risk of TB with Secukinumab
Jan 20, 2021
JAMA Dermatology has reported on a longitudinal cohort study of 12,319 secukinumab (SEC) treated patients (psoriasis, psoriatic arthritis, or ankylosing spondylitis); no new cases of active tuberculosis (TB) and very few cases of latent tuberculosis infection (LTBI) were found.
Read Article
Osteoporosis in Men - is often unrecognized till they fracture.
Links:
Dr. John Cush @RheumNow ( View Tweet)
Jan 20, 2021
ACR Convergence 2020 Fireside Chats – Top presentations in nr-axSpA, AS, axial PsA
Sponsored by Novartis Medical Affairs
Unable to attend all the key sessions at #ACR20?
Links:
Dr. John Cush @RheumNow ( View Tweet)
Jan 20, 2021
Results from Cohort Hip & Cohort Knee study (early symptomatic hip OA pts) finds that 1/9 went on to receive hip replacement during the 10-year follow-up.
Links:
Dr. John Cush @RheumNow ( View Tweet)
Jan 20, 2021
Dr Stanley Cohen has written a nice review of VTE with JAK inhibitors, points out that little/no risk during developmental trials, is not the same as a low risk seen with long term use in real world patients (older, higher BMI, more activity) https://t.co/0utVMqHdf
Dr. John Cush @RheumNow ( View Tweet)
Jan 20, 2021
Swedish Rheumatology Quality Register study of 46316 RA pts (322601 visits) shows RA has a higher risk of venous thromboembolism (RR 1.88;95% CI 1.65, 2.15) & this increased with disease activity (RR=2.03;1.73 to 2.38) (compared to remission).
Links:
Dr. John Cush @RheumNow ( View Tweet)
Jan 20, 2021
Dr. Janet Woodcock has been appointed the interim head of the FDA. President Biden has yet to nominate a new FDA commissioner. Dr. Woodcock is a rheumatologist and current Director of CDER at the FDA .https://t.co/Wk0auZ2pn1
Links:
Dr. John Cush @RheumNow ( View Tweet)
Jan 20, 2021
Sign up to attend RheumNow Live--March 20 and 21. CME credits available
https://t.co/vJlU0Z3Q3x https://t.co/Z0ectgFD2d
Links:
Dr. John Cush @RheumNow ( View Tweet)
Jan 20, 2021
Factors Predictive of SLE Flare After HCQ Taper/Discontinuation
MedPage Today
Jan 19, 2021
The benefits of hydroxychloroquine in lupus are many, but if you were to withdraw HCQ? A recent study of five Canadian cohorts, suggests that certain baseline variables, including age, race, and steroid use, were predictive of flare in patients with SLE who tapered or discontinued treatment with hydroxychloroquine.
Read Article
ACR Convergence 2020 Fireside Chats – top presentations in Still’s disease
Sponsored by Novartis Medical Affairs
Unable to attend all the key sessions at ACR Convergence 2020?
Links:
Dr. John Cush @RheumNow ( View Tweet)
Jan 19, 2021
From the blog
Zoomatology – Present in Absentia
Jan 06, 2021
Are you a zoomatologist or a doomsatologist? Zoom has replaced the meeting, the teleconference or the board meeting. If your old meetings were bad, then your replacement zoom meetings will also be bad, if not worse. Largely because you have failed to master the medium. Here are the new rules of Zoom.
Read Post
20,21 Whatever it Takes
Jan 05, 2021
Amazingly, we made it through 2020, a most forgettable year.
Life was great in the first 3 months of 2020, and then COVID hit the fan and a pandemic steamroller derailed life as we knew it.
Eventually we witnessed that lives either improved or worsened. Bartenders are out of a job, but teachers and nurses are busy morphing their skillsets. Some patients skipped out of visits, testing and medical plans. Yet, others exercised, lost 20 lbs. and signed up for telemedicine visits.
Recent Podcasts
QD Videos Week Of 1.10.2021Jan 16, 2021
RheumNow Podcast – Steroids, IVIG & the Vaccine (1.15.2021)Jan 16, 2021-
RheumNow Podcast – Lights, Camera, Zoom (1.8.2021)Jan 08, 2021
ACR Fireside Chats - Still's disease AbstractsJan 01, 2021-
ACR Fireside Chats - Spondyloarthritis AbstractsJan 01, 2021
Therapeutic Update
ACR Convergence 2020 Fireside Chats – Top Abstracts in nr-axSpA, AS, axial PsA and Still’s disease
Sponsored by Novartis Medical Affairs
Jan 01, 2021
